Erasca, Inc. (ERAS)
14.02
+0.66
(+4.90%)
USD |
NASDAQ |
Jun 11, 16:00
14.02
0.00 (0.00%)
After-Hours: 17:17
Erasca Accounts Payable (Quarterly) : 2.163M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 2.163M |
| December 31, 2025 | 0.981M |
| September 30, 2025 | 3.029M |
| June 30, 2025 | 1.663M |
| March 31, 2025 | 2.262M |
| December 31, 2024 | 0.468M |
| September 30, 2024 | 2.405M |
| June 30, 2024 | 2.142M |
| March 31, 2024 | 2.633M |
| December 31, 2023 | 2.00M |
| September 30, 2023 | 3.701M |
| Date | Value |
|---|---|
| June 30, 2023 | 2.631M |
| March 31, 2023 | 3.353M |
| December 31, 2022 | 23.05M |
| September 30, 2022 | 4.319M |
| June 30, 2022 | 2.291M |
| March 31, 2022 | 4.712M |
| December 31, 2021 | 4.677M |
| September 30, 2021 | 1.324M |
| June 30, 2021 | 1.507M |
| March 31, 2021 | 1.042M |
| December 31, 2020 | 0.878M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 80.54M |
| Tango Therapeutics, Inc. | 2.43M |
| Kymera Therapeutics, Inc. | 12.84M |
| Bridgebio Oncology Therapeutics, Inc. | 12.09M |
| ImmunityBio, Inc. | 11.19M |